Abstract Whether children should be offered genetic testing for cancer risk is much debated but young voices are rarely heard in these conversations. The current study explored perspectives of genetic testing held by adolescents and emerging adults in families with Li Fraumeni syndrome (LFS). Twelve 12-to 25-year-olds in families with LFS completed qualitative interviews for this study. All believed that testing should be offered for children but many qualified this statement saying parental approval would be needed and testing should be optional. Genetic testing was seen as way to learn of risk status, allow for disease prevention efforts, and reduce uncertainty and anxiety. Perceived disadvantages included negative emotions associated with the testing result. Participants generally felt that children should be involved in the testing decision, but that parents could unilaterally decide to have a child tested in certain circumstances (e.g., young age, high risk). All who were aware of having been tested and of their test result (n = 7; 4 positive) said testing had no negative impact on their outlook and they agreed with the decision to undergo testing. Implications of these findings for clinical practice and future research are discussed.
Introduction
Rapid technological advances in the field of cancer genomics have revolutionized the ability to search for and detect germline variations that increase cancer risk. With the growing application of these technologies to the pediatric oncology setting, increasingly difficult challenges related to the genetic testing process and communication of genetic test results are emerging (Feero et al. 2010; Green and Guyer 2011; Ross et al. 2013) . Currently, there remains debate as to whether and when children should be offered genetic testing for cancer risk and which genes should be examined as a part of the testing procedure (Kesserwan et al. 2016) . There is also great concern that the test results may have a negative impact on children. A recent review of the literature indicated that most studies examining pre-symptomatic or carrier testing for a variety of medical conditions have not identified a clinically significant effect of genetic testing on the self-perception, social well-being or emotional state of children and adolescents; however, the existing studies were characterized as methodologically limited, thus making it difficult to draw strong conclusions about potentially negative consequences of testing (Wade et al. 2010) .
When it comes to genetic testing specifically related to cancer risk, the child may not yet have developed cancer but nonetheless be part of a family with an extensive cancer history. Alternatively, the child may have a diagnosis of cancer with no significant family history, or may have a diagnosis of cancer in the context of a complex family history of cancers. Each of these scenarios may produce a psychological or emotional burden (e.g., Oppenheim et al. 2001) . Despite these concerns, cancer genetic testing holds great potential to improve long-term outcomes for at-risk children and adolescents by encouraging important lifestyle changes, such as adopting cancer surveillance (Masciari et al. 2008; Villani et al. 2011 Villani et al. , 2016 and health-promoting behaviors and avoiding cancer-promoting behaviors (e.g., use of tobacco products, excess unprotected sun exposure). Because of these potential health benefits, parents often express interest in the genetic testing of their children for cancer predisposition, but concerns about the impact of the information on the child remain (Alderfer et al. 2015; Borry et al. 2009 ). This concern is accentuated for adolescents, who are at a vulnerable developmental stage as they establish independence and a sense of personal identity (Fanos 1997) .
Empirical research on adolescents' perspectives of genetic testing during childhood for cancer-predisposing conditions are limited, but studies related to familial adenomatous polyposis (FAP) and hereditary breast cancer are now emerging. Genetic testing for FAP has medical management implications starting in the late school age or early adolescent years, so testing may occur starting around 10 years of age. Adolescents undergoing testing for FAP report positive as well as negative emotions post-testing (Duncan et al. 2008) . Positive emotions include relief from the uncertainty of not knowing whether or not they have an underlying mutation and feeling empowered and able to move forward and make appropriate plans. Conversely, negative emotions include anticipation of future illness, feelings of anxiety, anger, guilt and regret, and feeling distanced from family members and others. Longitudinal quantitative studies have shown no clinically significant changes in behavioral problems, symptoms of anxiety or depression, or self-esteem for children who undergo testing for FAP (Codori et al. 2003; Michie et al. 2001) . Further, undergoing genetic testing or being diagnosed with FAP was not associated with rates of psychiatric disorders (Gjone et al. 2011) . Within these quantitative studies, however, samples were small and heterogeneous, limiting statistical power to find such effects (Wade et al. 2010) .
Currently genetic testing for BRCA1 or BRCA2 (hereafter BRCA) alterations is generally not offered to minors mainly because effective risk reduction options are not recommended until early adulthood (Daly et al. 2006) . Studies of BRCA mutation carriers and their adult offspring indicate that many are concerned or opposed to testing minors for this cancer predisposition (Bradbury et al. 2008; Hamann et al. 2000) . Many teens, however, believe that actions can be taken during adolescence to prevent the occurrence of breast cancer (Bradbury et al. 2012 ) and learning about a parent's BRCA mutation status during adolescence or emerging adulthood leads some to adopt healthier lifestyles (Bradbury et al. 2009 ). Further, the limited literature to date suggests that a majority of adolescent girls within the general population is interested in pursuing genetic testing for breast cancer (67%) and that this percentage is higher (78%) among those with a family member who had breast cancer (Harel et al. 2003) . However, many adolescents may have an incomplete understanding of the potential risks and benefits of such genetic testing (Rew et al. 2010) .
To add to this literature regarding genetic testing of children for cancer predispositions, we chose to examine the attitudes of adolescents and emerging adults in families with Li-Fraumeni syndrome (LFS). LFS is a highly penetrant cancer-predisposing condition caused by heterozygous germline mutations in the TP53 tumor suppressor gene (Kamihara et al. 2014) . TP53 mutation carriers are prone to develop a variety of cancers, including soft tissue and bone sarcomas, early-onset breast cancers, adrenocortical carcinomas, acute leukemias, and brain tumors. Over their lifetimes, more than 90% of individuals with LFS develop cancer, with up to 40% experiencing cancer by the age of 20 years (Bougeard et al. 2015; Gupta and Malkin 2008) . Those testing positive after predictive testing may not develop cancer until adulthood, and although recent work has suggested that surveillance of asymptomatic individuals with LFS can reduce cancer mortality (Masciari et al. 2008; Villani et al. 2011) , the degree to which knowledge of TP53 mutation status during childhood confers medical benefit remains uncertain. Still, parents may seek out testing for their minor children or be offered testing in the context of research or clinical care when their child presents with a cancer linked to a TP53 mutation and/or when the family history of cancers suggests LFS.
Our previous work reported rates of uptake of TP53 genetic testing for children in this population, parents' process in making decisions regarding genetic testing for their children, and their perceptions of the advantages and disadvantages of testing (Alderfer et al. 2015) . Parents with difficulty making the testing decision reported an overriding concern that their children could experience negative psychosocial consequences of the testing and results. Empirical data regarding the perspectives and experiences of these adolescents and emerging adults is lacking, however. The current study begins to fill this gap through qualitative interviews with adolescents and emerging adults in families with LFS by examining their understanding and expectations of genetic testing and the psychosocial implications of the testing and results.
Methods Procedure
Conducted through The Children's Hospital of Philadelphia (CHOP) in 2012-2013, this study recruited participants from CHOP, The Hospital for Sick Children, Dana-Farber Cancer Institute, Huntsman Cancer Institute, the National Cancer Institute Clinical Genetics Branch, Texas Children's Hospital, and Stanford University. All procedures were approved by the Human Subjects Protection Committees of each institution, as required.
The participants were recruited from families taking part in a larger study of parent decision-making around genetic testing for children (Alderfer et al. 2015) . In the parent study, recruitment letters were sent by host institutions to English-speaking families with at least one member who was offered TP53 genetic testing before 22 years of age. Families interested in participation contacted researchers by e-mail or telephone. In the parent study, purposeful sampling ensured representation of individuals offered diagnostic and predictive testing and those agreeing to and refusing testing.
After completion of the parent study, participating families with adolescents/emerging adults between the ages of 12 and 25 were re-contacted and told that the researchers were interested in interviewing the adolescents/emerging adults within the family regarding their opinions of genetic testing. All adolescents/emerging adults in this age group were approached regardless of testing status. Parental consent and assent were obtained for those under age 18; informed consent was obtained from participants aged 18 and older. A psychologist (M.A.) and pediatrician (R.L.) administered telephone interviews to all participants using a semi-structured interview guide developed for the current study. Interviews were recorded and transcribed for analysis. Parents did not participate in the interview, although some adolescents chose to complete the interview with a parent present. Each participant received $25 for completing the study. For this manuscript we report the perspectives of the adolescents/emerging adults in families with confirmed LFS.
Measure
The interview guide was carefully crafted with no assumptions regarding the participants' knowledge of their or their families' experiences with genetic testing and no provision to them of the information gathered during the parent interviews. The interview was organized thematically and included prompts and skip instructions to ensure participants were not asked irrelevant questions. It began by asking all participants if they had ever heard of genetic testing and what they knew about it. Regardless of the response, participants were then read a brief paragraph explaining genetics and genetic testing as a means for determining if someone has inherited a Bgene change^and indicating that genetic testing is done through a blood test. Participants were then prompted to discuss their: 1) personal/family experiences with genetic testing; 2) perceived cancer risk; 3) general opinions as to whether children should be offered genetic testing; 4) perspectives on the advantages and disadvantages of genetic testing; 5) opinions regarding involvement of children in the testing decision including their own experience (if applicable); and, 6) experiences with cancer surveillance or screening. The interview guide is available upon request.
Data Analysis
Descriptive statistics (means, standard deviations) were used to characterize the sample. The brief, mainly experiential questions of the interview guide invited use of a descriptive content analysis approach (Schreier 2012) and simple coding framework. Using Microsoft Excel, interview responses were grouped into the six major topics listed above under Measure. For basic questions (e.g., BWas testing offered for you?^, BWere you tested?^), responses were classified (e.g., yes/no) and summarized. For questions that generated more detailed, nuanced responses (e.g., BWhat has changed now that you have gone through testing and gotten the results?^), participant responses were coded using an inductive framework (Elo and Kyngäs 2008) and then reviewed to identify broad themes. A second coder independently reviewed each transcript for the presence/absence of these themes; discrepancies were resolved by a third coder.
Results

Participants
Of the 39 families in the parent study, nine had LFS and adolescents/emerging adults in the target age range.
1 Seven of these nine families (78%) agreed to participate. Across these seven families, 15 adolescents/emerging adults were eligible for the study and 12 (80%) completed interviews. Participants ranged in age from 12 to 25 years (M = 17.8, SD = 4.82); additional demographics are detailed in Table 1 . Interviews ranged from 16 to 40 min in length (M = 25.2; SD = 7.8).
Knowledge of Personal/Family Experience with Genetic Testing
Figure 1 provides information regarding the genetic testing experiences of the 12 adolescents/emerging adults providing data for this manuscript. According to their parents' reports, 10 of these 12 participants were offered and had undergone TP53 genetic testing. Based on their responses to the qualitative interview, seven of these 10 (70%) adolescents/emerging adults reported that they had undergone testing (one reported being told within days of participating in the project) and three indicated no knowledge of having been offered or undergoing testing. Those with no knowledge of the testing were young at the time of the offer of testing (aged three to eight years). Furthermore, their testing had been performed seven to 15 years prior to the interview. Those reporting knowledge of their testing were aged nine to 20 years at the time of the offer of testing and they received testing three to six years prior to the interview. Two of the three who were unaware of their own testing reported that family members had been offered and had completed testing (one reported learning this within days of participating in the project). Of the two who had not received testing, one reported being offered testing and was planning to be tested. According to parent report, testing was not offered for the remaining participant who was assumed positive based upon parent mutation status and a personal history of cancer. All of those in our sample who tested (or were assumed) positive were undergoing cancer surveillance protocols and knew this was because their family was at high risk for cancer. Not all of these individuals knew they had tested positive and that LFS was diagnosed in their families. In fact, three participants across two families gave no indication that they were aware that LFS had been diagnosed in their family (all aged under 13 at the time of the interview).
Should Genetic Testing for Cancer Predisposition be Offered for Children?
All of the participants believed that genetic testing should be offered for children; however, half of the sample (n = 6) spontaneously put one or more qualifications on this statement. Two participants asked if the question referred to all children or just those in families with known mutations, but then both indicated that it could be offered to children in either case if the parents and/or the child wanted to know. For example, one participant said, BI mean, just randomly deciding to do it? That's -I mean, if a parent wants to know, that's fine.^(21-year-old). Two participants (17%) mentioned that parental approval would be needed. Three participants (25%) commented 12 participants (7 families 
Perceived Advantages of Testing
The most frequently mentioned advantages of genetic testing for children (see Table 2 ) were to learn of risk status or genetic predisposition for disease (100%) and to allow for disease prevention efforts such as living a healthier lifestyle and engaging in screening to allow for early disease detection and treatment (n = 11; 92% Similarly, another participant commented, BIt's worth it to know so that you can have the screenings done … making it so that you can take better care of yourself. It's just something else to know about your body, you know, about your history, so you can take care of yourself in the best way possible,^(25-year-old).
Half of the participants (n = 6) mentioned that knowing one's risk status, regardless of the result, allows one to prepare, reduces anxiety and increases one's power in the situation. One participant stated: BI really wanted to know whether or not I had that [the mutation], so that I wouldn't have to worry anymore about if I had it or not,^(12-year-old). Another commented, BI was a little worried, but then I got over it and I was like, okay, I'm all right now and now we know that I can be checked up, B(15 year old). Another participant explained, BKnowing or not doesn't change anything in terms of my actual risk … but (with) more knowledge, I can be better armed to take care of it. … knowledge is power,( 25-year-old).
Some participants also mentioned possible benefits of genetic testing to the family and specifically future generations (n = 4; 25%). For example, one participant commented, BI guess if something came up with my kids and they needed to know if I carried the gene, then, you know, I would do it [genetic testing] for their sake,^(23-year-old). Others spoke about the importance of knowing their genetic status in advance to avoid passing LFS, the need for screening, and the possibility of cancer onto the next generation. A couple participants (17%) mentioned that the testing could make contributions to medical research. One participant said, BI think that doing this would help the doctors and all that, kind of figure out a bit more, take one step forward, instead of staying where they were,^(15-year-old). The other stated: BIt's interesting, it's weird, it's rare, it's cool from a scientific perspective, so I am more than happy to be able to enroll in [research] and to increase knowledge about it,^(25-year-old).
Perceived Disadvantages of Testing/Advantages of not Testing
Nearly two-thirds of the sample (n = 7) reported that negative emotions associated with a positive result were a potential disadvantage of testing and/or that absence of worry was a benefit of not testing. The participants mentioned the possibility of shock, anger, disappointment, worry, and fear associated with testing. For example, BI guess if you found out that you do have a disease, it would be upsetting,^(13-year-old). Another participant explained B… the whole 'ignorance is bliss' factor. So if you had a gene mutation, it doesn't necessarily mean that you're going to develop full-blown cancer, but it's there and (confirmed by testing) it's something you have to live with,^(25-year-old).
Some participants (n = 4; 36%) spontaneously indicated that the possibility of experiencing these negative emotions is offset by the benefits or limited to individuals with a predisposition to worry. For example, in response to a question about disadvantages of genetic testing, one participant stated: BNot really. I mean, learning you have it could be a shock, but in the end, it's better to know,^(21-yearold). Similarly, a second participant said, BI know that some people do get worried about getting -like uncovering some type of thing that they would be worried about, but for me, no,^(20-year-old).
Other reported disadvantages of testing included physically undergoing the blood test (n = 4; 36%) including feeling nervous in advance, anticipating pain, Bbeing stabbed^and seeing blood. One participant indicated that the testing could be a waste of time, because there is not much one can do about having a genetic predisposition, the result may be negative, or the risk may not manifest in cancer. Single participants also mentioned potential difficulties obtaining insurance and the expense of testing as disadvantages.
Should Children be Involved in the Testing Decision?
All of the participants indicated that children should be involved in the decision regarding whether or not to get genetic testing, to an extent, and that parents could unilaterally decide to have their children tested for genetic cancer predispositions without involving their child under certain circumstances. Ten participants (83%) felt that the age of the child was an important consideration. Generally, across participants, it was accepted that children younger than age six did not need to be involved in the decision and that those aged 10 through 15 should definitely have some say. As one participant explained:
B…if you told someone who was six, they wouldn't get it at all, … but once they're nine or ten, I think they would understand what's going on,^(12-year-old). One participant indicated that children of any age should be able to refuse testing if the test were invasive or painful in any way (including a blood test).
Nearly half of the sample (n = 5; 42%) indicated that regardless of the child's age or opinion, if the child was at high risk and the parents thought it best, the parents could unilaterally decide in favor of testing. For example, when asked when it would be okay to not involve a child in the decision, one participant remarked, BParents make medical decisions for their children all the time and I think that if it were something important for the parents to know to be able to take care of their child, then I think they would be justified in doing it without involving the child,^(25-year-old). One participant felt that if either the parent or the child wanted the testing, regardless of the opinion of the other party, the testing should be made available. Only one participant indicated that parents should wait for children to age, mature, and understand the process enough to be part of the testing decision and that perspective paralleled the participant's own experience. This same participant still reported that if the child had had cancer and was very young, the parents could unilaterally decide in favor of the testing.
The child's ability to make decisions was also a consideration mentioned by three participants (25%). As one participant stated, BI guess if they have a bad sense of judgment, or like they can't make decisions for themselves, or if they can't -they need help and they can't be on their own, like if they have a disability,^(15-year-old).
Actual Child Involvement in Testing Decision and Satisfaction with Involvement
The eight participants who knew they had been offered and/or had gone through testing were asked who made the decision regarding the testing. Two participants, in the same family, over age 16 at the time of the decision and undergoing predictive testing, indicated that they had the ultimate decision regarding testing but family members were involved: BI was allowed to decide whether I wanted to or not, but I discussed it with my parents and my sister and my family,^(21-yearold). Two participants indicated that they and their parents made the decision together. One had had cancer and was tested during treatment (at age 16); one was planning but had not yet received testing (currently aged 12). Two participants indicated that their parents made the decision, but that they could have refused the testing: BI could have said no, but my mom just said that she made the appointment to go get tested, if I wanted to go, so I figured, why not?^These participants were 12 and 18 at the time of testing. The remaining two indicated that their mother or parents made the decision alone. These two were age nine and 10 at the time of testing.
All eight participants indicated that they had enough say in the decision-making process. Those not involved in the testing decision reported that this was appropriate given their age at the time. They also stated that they trusted their parents' judgment, would have gone along with the decision if asked, and knew that their parents had their best welfare in mind. As one commented: BMy mom just pretty much told me, 'you're getting a blood test to see if you have this or not.' (Do you feel like you should have had more say in the decision?) No. I was younger and if my mom said, 'hey, do you want to go check to see if you have this or not?' I would have probably said yes anyway,^(16-year-old).
Thoughts about Testing and Factors Influencing the Decision-Making Process
Of the four participants involved in the decision regarding testing, two (50%) reported that they considered the impact the results of the testing might have on their future prior to testing. One considered the need for cancer surveillance and health behavior changes (16 at time of testing), and the other (18 at the time of testing) thought about possible implications for romantic relationships: BI was just kinda thinking about, you know, that could be hard with relationships. Like if you were in a relationship with someone and you knew that you had this ticking time bomb within you( 23-year-old). These thoughts did not deter the participants from moving ahead with testing.
One participant, going through cancer treatment at the time of testing (at age 16), reported not thinking much about the decision regarding testing because of the demands of treatment: BThey were doing stuff to me all day, essentially, so it wasn't like, I didn't think about it much. I think that had I not been sick and coming in for a special visit, just for that, I think it would have been different.^Two participants, from the same family, indicated that the decision to do the testing was influenced by the fact that other family members were also being tested: BHad I been entirely by myself, I'm not sure whether I would necessarily have made the same decision. Because my whole family was getting tested, it was very easy to go along and be part of that process,^(25-year-old). Two participants indicated that not perceiving LFS as a death sentence influenced their decision: BIn some Li-Fraumeni families, it's basically a death sentence. Had that been the case in my family, had that been my experience with it, my desire to be tested may have been very, very different,^(25-year-old).
Impact of Testing and Results
The seven participants who were aware of undergoing testing were asked about the impact of the testing and results on various aspects of their lives. Three participants, all of whom tested positive, indicated that the seriousness of having this mutation/deletion and the lifelong implications did not set in until after testing when the details of the surveillance procedure were known: BIt didn't sink in at first, but once I started having to get all of the testing, it sunk in that I am going to have to deal with this for the rest of my life,^(16-year-old) All three indicated that they have now accepted this fact. Most participants indicated that testing and the results have had no impact on family relationships (n = 4; 57%). The remaining three participants represented a single family in which two children tested positive and one negative. One participant from this family stated: BIt probably brought me and my sister closer together because we now have something (testing positive) that we can closely relate to^(16-year-old). The child testing negative within this family reported: BA feeling of guilt that I don't have it. My brother and sister need to deal with this for the rest of their lives,^(23-year-old). No participants indicated that testing had an impact on their friendships.
When asked about how the testing and results affected plans for their future, three participants who tested positive made comments about careers. One abandoned plans to enroll in the military, one reported being inspired to go into a career in nursing or genetics, and the third indicated that testing positive had no impact. Four participants made comments about having children: adoption and pre-implantation screening were mentioned by two participants who had tested positive, a third testing positive indicated that passing on the mutation was not a current concern. The fourth was relieved that their negative result meant that their children would not have the mutation.
When asked how testing and the results shaped their outlook, all participants indicated no change or a positive change, even when their result was positive: BI don't really feel that it's changed my sense of who I am or what I want to do with my life, or what my life options are in any way,^(25-year-old). One participant, a cancer survivor, said: BIt made me have a passion for life. I'm not upset about it. I have accepted it. … I try to be a good friend and a good daughter because life is too short to not, I guess. I feel like I've always been like that. I guess it's probably more extreme … so I feel like it's positively affecting me,^(21-year-old). All of the participants who underwent genetic testing said that they would do the testing again.
Discussion
This qualitative study is the first to explore perspectives of genetic testing among adolescents and emerging adults in families with LFS. Developing an understanding of this perspective is important to provide adolescents/emerging adults and their families with appropriate and effective genetic counseling and medical management. Through this study, a wealth of information was gathered from adolescents and emerging adults regarding their perspectives on offering genetic testing to children, perceived advantages and disadvantages of testing, involving children in the decision to test, and the psychosocial and behavioral impact of the testing and results.
The entire sample indicated that genetic testing to determine risk for cancer should be offered for children. This level of interest in testing is high. Many adolescent girls with a family history of breast cancer also express an interest in predictive genetic testing for cancer risk (Harel et al. 2003) . As many adolescents and emerging adults with a suspected risk for cancer want to learn whether or not they have a genetic predisposition, it is important to understand the reasons behind and factors influencing such preferences.
Despite the high level of interest in genetic testing, half of the participants who indicated that genetic testing for cancer risk should be offered to children qualified their statement in some fashion. They commented about the risk level of the child, approval of parents and ensuring that that testing is optional. These comments suggest an appreciation among many of the participants that offers of genetic testing for children should consider the wants and needs of the child and family. The process of uncovering and meeting these needs is consistent with professional suggestions regarding the establishment of an effective genetic counseling relationship between the family and the medical provider.
A range of perceived advantages to testing were reported including: a) learning of risk status; b) allowing for disease prevention efforts; c) reducing uncertainty and anxiety, increasing empowerment, and allowing for preparation; d) benefiting the current family and future generations; and e) contributing to medical research. These benefits are similar to those reported by parents in these same families (Alderfer et al. 2015) and by adolescents/emerging adults regarding genetic testing for other cancer predisposition syndromes (Bradbury et al. 2009; Duncan et al. 2008) . It is important to note that despite this perception, there is not robust empirical evidence demonstrating that early detection and intervention improves outcomes. More research is needed into how and what parents of children offered testing for TP53 mutation communicate about cancer risk and the benefits of testing to their children.
The most frequently mentioned disadvantage of genetic testing was possible worry and other negative emotions associated with the result or the testing itself. Many participants mentioning this disadvantage went on to state that they personally did not experience negative emotions or that any negative emotions they did experience were transient and/or offset by the benefits of testing. Only one participant reported experiencing a sustained negative emotion -guilt about testing negative when siblings tested positive. Nonetheless this participant, like all others in our sample regardless of test results, reported no regret about getting tested.
One participant mentioned that testing could be a waste of time (i.e., if the result is negative, if the risk doesn't ever manifest in cancer, if nothing can be done to prevent cancer). This possible disadvantage was not reported by parents within these families and may reflect a developmental difference in the perceived burden of testing or value of a negative result. For example, a few adolescents/emerging adults in this study raised concerns about having to undergo a blood draw. Parents also reported that an advantage of genetic testing is the possibility of learning why cancers occur within their families (Alderfer et al. 2015) ; adolescents and emerging adults did not mention this possible benefit.
Nearly all of the participants believed that children should be involved in the decision whether or not to undergo genetic testing, depending upon age and risk status. The general consensus was that 10-to 15-year-olds should definitely have some say, however, those aged six or under did not need to be involved. Many participants believed that, regardless of age, if the child were at high risk and the parents thought it best, parents could unilaterally decide whether or not the child should receive testing. Interestingly, only one participant suggested that the parents should wait for the child to age and mature so that they could be part of the decision-making process. These varied opinions illustrate the importance of carefully eliciting the perspectives of adolescents and emerging adults regarding genetic testing during pre-test genetic counseling. Many unique perspectives were expressed, and each has ramifications for the level of child involvement in the decision and/ or acceptance of the parents' prior decisions regarding testing.
Most participants indicated that the testing and results had no impact on their relationships with others, their plans for the future, or their outlook on life. Among the few who reported an impact, positive effects were mentioned just as frequently as negative effects. More research is needed with larger samples to substantiate this finding; however, it provides some reassurance that genetic testing during childhood for LFS does not typically have deleterious consequences in the limited follow-up period of this study. It could be that these effects manifest as the prevalence of family malignancies increases, or as these adolescents and emerging adults continue to mature and become parents themselves.
Of the eight participants in our study that were aware of being offered and/or undergoing genetic testing, only two reported considering the impact that the results of the testing might have on their future prior to testing. Three participants indicated that the seriousness of having this mutation/deletion and the lifelong implications did not set in until the positive result came back and the cancer surveillance procedures were put in place. This style of approaching the decision is not unlike that of some parents. In our previous work we found that 44% of the time parents made Bautomatic^decisions regarding genetic testing -they uncovered a benefit of testing that they wanted to pursue (e.g., promoting the health of their child; satisfying a Bneed to know^) and did not focus on the possible drawbacks or implications of the testing (Alderfer et al. 2015) .
Study Limitations
The findings of this study need to be considered within the context of its methodological limitations. Our sample was small, heterogeneous and may be biased. Those with more negative views or experiences of genetic testing may not have participated, limiting the range of reported disadvantages and negative effects. The study design was qualitative, aiming to launch research in this area and identify a range of opinions and themes, however, the resulting sample, while limited to families with LFS, still represented a wide range of ages and experiences (e.g., personal history of cancer, involvement in testing decision, mutation status). The size of the sample was too small to reach saturation of themes within each subgroup and make comparisons. Still, the perspectives of the participants are valuable, encouraging, and informative, particularly since this is the first study of its kind.
Practice Implications
The results of this study raise several points with important implications for the practice of cancer genetic counseling and testing of children. First, this study supports the importance of developmentally-appropriate conversations between children, parents and providers prior to genetic testing of children. Adolescents and emerging adults see a role for children in these discussions starting in mid-childhood and they uniformly agreed that teenagers should be involved depending upon their level of cognitive and emotional maturity. Such discussions should review cancer risk, detail the potential advantages and disadvantages of testing, and present testing as optional. These issues are important to teens and emerging adults when faced with decisions regarding genetic testing.
Many adolescents/emerging adults in our sample reported making the decision to undergo testing without fully considering the consequences of a positive test result. This finding suggest that during the course of genetic counseling, parents and practitioners should be aware that children, adolescents and emerging adults may benefit from receiving developmentally-appropriate information about the cancer surveillance plans that will be recommended in the event of a positive result prior to testing. In the event of a positive result, ongoing conversations may be needed between the family, genetic counselor and medical providers, as the child moves through different developmental stages, to foster ongoing appreciation and understanding of the need for surveillance and the long-term implications of the test result.
If the child is young at the time of genetic testing, the provider should inquire about parents' plans to involve the child in the testing decision. Sharing the findings of this study with parents may help them in their process of deciding whether or not to involve the child or to feel more at ease with the decision to not involve the child. Our data indicate that adolescents and emerging adults understand and accept that parents sometimes need to make unilateral healthcare decisions for their children and that genetic testing is not an exception. When children are not involved in the decision it is important to follow-up with parents and help them plan for having discussions with their children about the testing and results when it becomes age-appropriate. Within our sample, those who were under age nine at the time of testing reported no knowledge of having undergone testing and three of the seven adolescents/emerging adults who tested positive were unaware of this fact; they were all currently under the age of 14. Parents may need support in deciding when and what is best to tell their children who were tested at young ages. Towards this end, we recommend that parents and children who are tested at a young age meet at least once again with a genetics professional (clinical geneticist, genetic counselor) or their primary provider during adolescence to review the results of prior LFS testing and discuss the implications of positive test results on future cancer risk and potential recurrence of LFS in their offspring. Furthermore, ongoing discussions with genetics professional should be available to all older adolescents and emerging adults who test positive to assure that they develop an accurate understanding of their test results, and acquire the skills they will need to independently access the health care they require within the context of life-long cancer risk.
Finally, it is important to recognize that children undergoing testing may also experience significant negative feelings, even when the result is negative. Guilt over a negative result has been previously documented (e.g., Duncan et al. 2008) and is easily understood. Accordingly, it is imperative that genetic counselors and medical providers remember to question families in post-test counseling sessions about their children who test negative as well as those who test positive and provide follow-up support for these individuals, as appropriate.
Research Recommendations
Research into the perspectives of adolescents and emerging adults regarding genetic testing during childhood for cancer predispositions is in its infancy. Accordingly, more qualitative research with larger samples of adolescents and emerging adults with similar experiences (e.g., those learning during adolescence of having been tested in early childhood; those testing positive during adolescence) is needed. This work should be longitudinal, prospective, and in real time to capture effects as they occur. Such work would give a voice to the experiences and needs of adolescents and emerging adults being offered cancer genetic testing. To complement this work, larger-scale prospective longitudinal quantitative studies are needed to better evaluate the short-and longer-term psychosocial impacts of the cancer genetic testing experience. Given the rarity and heterogeneity of genetic cancerpredisposing conditions, this type of research can only be accomplished through international collaborative groups with access to a large number of affected families. Parents are concerned about the impact genetic testing may have on their children, and some struggle with decisions regarding testing because there is simply not enough empirical evidence as to the psychosocial impact of this information. More research is clearly needed to best serve the needs of these families.
